Three distinct categories of HAE are acknowledged, and Types I and II are linked to genetic mutations that affect the production of the C1 inhibitor protein (C1-INH), a serine protease inhibitor that plays a critical role in regulating the kallikrein-kinin system (Ref 109). The gene discussed is KLK4; the disease is hereditary angioedema.